---
title: Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s Disease
euct_id: 2023-503203-29-00
phase: Phase 3
status: Completed
sponsor: Nodthera Limited
canonical_url: "https://parkinsonspathways.com/trials/eu/2023-503203-29-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2023-503203-29-00"
ctis_last_updated: "2024-12-19T02:06:36.456965629"
source: EU Clinical Trials Information System (CTIS)
---
# Effects of NT-0796 in Healthy Volunteers and Patients with Parkinson’s Disease

**EU CT Number:** [2023-503203-29-00](https://euclinicaltrials.eu/ctis-public/view/2023-503203-29-00)

## Key Facts

- **Phase:** Phase 3
- **Status:** Completed
- **Sponsor:** Nodthera Limited
- **Start Date:** 2023-04-04
- **Completion Date:** 2023-07-17
- **Conditions:** Parkinson's Disease, Disease Parkinson's

## Member States

Trial is authorized in 1 member state: Netherlands.

## Sites (1)

- QPS Netherlands B.V., Groningen, Netherlands

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's Disease; Disease Parkinson's
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2023-503203-29-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2023-503203-29-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2023-503203-29-00*